This Global Pricing & Market Access position, will support Celgene’s Immune-Oncology portfolio as well as inform the future disease strategy for new compounds and indications in this area. He/she will be a key strategic market access representative on the Global Project Teams (GPTs) providing support to the appropriate indications as needed to ensure optimal clinical development strategies (informing appropriate endpoint and trial design), adequate representation and execution of outcomes research projects, input on price forecasts & expectations, and proactively identifying ways to optimize lifecycle plans. He/she will be expected to provide advanced input on payer strategy, health outcomes differentiators, demand expectations, and general market access viability. The individual is expected to work collaboratively with regional/local teams in their planning and execution of launch & access strategies, as well as work collaboratively with the organizations with which Celgene has strategic alliances / collaborations.
Responsibilities will include, but are not limited to, the following:
Ownership of input into the Oncology programs and informing of Pricing and Market Access potential across different indications and diseases (across all stages of lifecycle development)
Identification of payer needs (unmet medical need, suitable comparators and competitive space) and anticipation of their reaction to Celgene lifecycle products.
Execution of a plan to address identified evidence gaps through HEOR studies, publications, messaging and influencing.
Development of the product’s value proposition and steering the development/updating of the product value repositories (Health Economic model, value story, commercial toolkit) for launching indications
Protocol design for early and registration studies, health economic studies and integration of payer relevant endpoints in the clinical development plans.
Identification of relevant and commercially attractive assets (including price potential) in the product pipeline in terms of a value proposition as well as the market need compared to existing or upcoming therapeutic alternatives in the respective indications.
Commissioning and preparation of health economic & outcomes research analyses necessary for reimbursement submissions & competitive messaging.
Providing input on cost-effectiveness analyses (CEA) / budget impact models (BIM) / systematic literature reviews (SLRs), indirect/mixed treatment comparisons, RWE generation strategies and approaches across the Heme Onc team
Market research and provision of regular updates on the competitor landscape for Celgene’s individual product indications and implications on market access.
Significant participation with advanced strategic contribution, in Celgene’s Global product teams (GPTs).
Has an in-depth understanding of payers and their perspective in the key worldwide markets, as well trends in Pricing & Reimbursement.
Has a solid scientific background enabling the assessment of trial design impact on payer strategies and the ability to challenge clinical development or medical affairs or other relevant stakeholders.
Has an ability to interpret and critique clinical study protocols, as well as identifying relevant clinical endpoints and conducting outcomes research in the early phases of clinical trial development.
Has an established and extensive network of payer contacts (pricing, reimbursement, policy, insurance) and KOLs.
Has competitive intelligence, identifies early opportunities and threats in the market and creates solutions to benefit from opportunities and to disarm threats.
Has ability to identify key product advantages in the context of market requirements and provides key ideas for developing individual value stories around Celgene’s products.
Can effectively liaise with Celgene Medical Affairs and Global franchise teams as well as Celgene’s local and regional teams, creating an efficient working style within a diverse organizational matrix.
Preferably has multi-year experience with health authorities, governmental economists and reimbursement agencies, hospital administrators and health care insurance companies’ general management, acquired at pharmaceutical companies, sickness funds, physician associations or health care consultancy companies.
Has an in-depth knowledge of the latest pricing, reimbursement and HEOR methodologies and approaches in the marketplace and how they can be employed to advance product value propositions
Ideally has at least ~10 years’ experience in the health care field, including significant experience in pricing, reimbursement, outcomes research or health economics, in Oncology / Immune-Oncology
Has graduate level (Master or higher) training in health economics or an analytical commercial discipline.
Displays excellent business English skills, with first-rate communication abilities.
Has strong influencing/negotiation skills and the ability to work at peer-level with experienced technical and commercial experts in other departments
Displays business confidence to constructively challenge marketing and clinical colleagues
Has excellent written, verbal and interpersonal communication skills, with the ability to communicate complex or technical content in a convincing way to non-technical audiences.
Is a flexible team member with a positive attitude, ability to work collaboratively and cross-functionally and the ability to prioritize projects.
Is experienced and adept at navigating international, multi-lingual, and cross-functional organizational matrices within a diverse and cross-cultural work environment
Is experienced in managing multiple projects simultaneously and delivering results in a timely manner
Corporate / senior, executive
Summit , United States